Approval · Notice of Compliance 23545 · 2020
RUXIENCE: Notice of Compliance 23545
Issued May 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23545
- Date
- May 4, 2020
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- RITUXAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RUXIENCE | 02495724 | Marketed |
Medicinal ingredients
- RITUXIMAB 10 MG per ML